Nuveen
BBOT icon

Nuveen’s BridgeBio Oncology BBOT Stock Holding History

Nuveen’s Portfolio BBOT Stock Details BBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.76K Buy
+960
New +$7.46K ﹤0.01% 4736

Other funds holding BBOT

Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Regents of the University of California
Regents of the University of California Oakland, California $6.64B AUM 23.46% 1-Year Est. Return
Laurion Capital Management
Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Nuveen's BBOT Position: Q3 2026 in Review

Nuveen opened a new position in BridgeBio Oncology (BBOT) in Q3 2026: 960 shares worth $3.76K. The stake represents ﹤0.01% of the portfolio and ranks #4736 among its holdings.

16 funds tracked by Wall St. Rank hold BBOT as of Q3 2026.

  • Nuveen held 960 shares of BridgeBio Oncology worth $3.76K as of Q3 2026.
  • BridgeBio Oncology was a new Nuveen position in Q3 2026.
  • BridgeBio Oncology made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4736 holding.
  • 16 funds tracked by Wall St. Rank held BridgeBio Oncology as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.